Download PDF
Thromb Haemost 1997; 78(03): 1069-1078
DOI: 10.1055/s-0038-1657689
Rapid Communication
Schattauer GmbH Stuttgart

Fibrin Detected in Plasma of Patients with Disseminated intravascuiar Coagulation by Fibrin-specific Antibodies Consists Primarily of High Molecular Weight Factor XIIIa-crosslinked and Plasmin-modified Complexes Partially Containing Fibrinopeptide A

Susanne A Pfitzner
The University of Heidelberg, Klinikum Mannheim, First Department of Medicine, Mannheim, Germany
,
Carl-Erik Dempfle
The University of Heidelberg, Klinikum Mannheim, First Department of Medicine, Mannheim, Germany
,
Michio Matsuda
1   Division of Haemostasis and Thrombosis Research, Institute of Hematology, Jichi Medical School, Tochigi, Japan
,
Dieter L Heene
The University of Heidelberg, Klinikum Mannheim, First Department of Medicine, Mannheim, Germany
› Author Affiliations
Further Information

Publication History

Received 22 1996

Accepted after revision 21 April 1997

Publication Date:
30 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Pooled plasma from 40 patients with severe disseminated intravascuiar coagulation (DIC) secondary to septic conditions was subjected to gel permeation chromatography on Sephacryl S-500 HR after sample pretreatment with KSCN for dissociation of non-covalent fibrin complexes. Fibrin antigen in eluates was detected by an array of ELISA tests, using two monoclonal antibodies against fibrin degradation product D-dimer, a monoclonal antibody against an epitope generated by plasmin cleavage of the D-domain, and an antibody against the neo-N- terminus of the α-chain of fibrin exposed by cleavage of fibrinopeptide A. Tag antibodies were a polyclonal antibody against the fibrinogen/ fibrin D-domain, a POD-conjugated version of the monoclonal antibody against fibrin α-chain neo-N-terminus, and a polyclonal antibody against fibrinopeptide A. Most fibrin-related material present in the pooled DIC plasma was of higher molecular mass than fibrinogen. Fibrin polymers were reactive with antibodies against D-dimer, plasmin cleaved D-domain, and fibrin α-chain neo-N-terminus. Part of the polymers reacted with antibodies against fibrinopeptide A, indicating presence of fibrinogen or desA-fibrin monomer within the covalently linked complex. In conclusion, the primary analytes detected by monoclonal antibodies for D-dimer, plasmin-specific epitopes of fibrin degradation products, as well as sites exposed by fibrinopeptide cleavage in plasma from patients with disseminated intravascuiar coagulation are high molecular weight factor XIIIa-crosslinked fibrin complexes, containing plasmin-cleaved D-domains, intact fibrin monomer units, and fibrinogen or desA-fibrin monomer.

 

  • References

  • 1 Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN. Measurement of crosslinked fibrin degradation products – an immunoassay using monoclonal antibodies. Thromb Haemost 1983; 50: 591-594
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Whitaker AN, Elms MJ, Masci PP, Bundesen PG, Rylatt DB, Webber AJ, Bunce IH. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 1984; 37: 882-887
    CrossrefPubMedGoogle Scholar
  • 3 Carr MEJ. Disseminated intravascular coagulation: pathogenesis, diagnosis, and therapy. J Emerg Med 1987; 05: 311-322
    CrossrefPubMedGoogle Scholar
  • 4 Whitaker AN, Rowe EA, Masci PP, Gaffney PJ. Identification of D-dimerE complex in disseminated intravascular coagulation. Thromb Res 1980; 18: 453-459
    CrossrefPubMedGoogle Scholar
  • 5 Carr JM, McKinney M, McDonagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol 1989; 91: 280-287
    CrossrefPubMedGoogle Scholar
  • 6 Bredbacka S, Blombäck M, Wiman B, Pelzer H. Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiol Scand 1993; 37: 125-130
    CrossrefPubMedGoogle Scholar
  • 7 Ott P, Astrup L, Jensen RH, Nyeland B, Pedersen B. Assessment of Ddimer in plasma: diagnostic value in suspected deep venous thrombosis of the leg. Acta Med Scand 1988; 224: 263-267
    PubMedGoogle Scholar
  • 8 Mirshahi M, Soria C, Soria J, Faivre R, Kieffer Y, Bassand JP, Toulemonde F, Caen J. Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis. Thromb Res 1988; 51: 295-302
    CrossrefPubMedGoogle Scholar
  • 9 Ginsberg JS, Siragusa S, Douketis J, Johnston M, Moffat K, Stevens P, Brill Edwards P, Panju A, Patel A. Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis. Thromb Haemost 1995; 74: 833-836
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Speiser W, Mallek R, Koppensteiner R, Stumpflen A, Kapiotis S, Minar E, Ehringer H, Lechner K. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemost 1990; 64: 196-201
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Boneu B, Bes G, Pelzer H, Sié P, Boccalon H. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 1991; 65: 28-31
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Bounameaux H, de MoerlooseP, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview [see comments]. Thromb Haemost 1994; 71: 01-06
    PubMedGoogle Scholar
  • 13 Mao SJ, Rechtin AE, Krstenansky JL, Jackson RL. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin. Thromb Haemost 1990; 63: 445-448
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Scheefers Borchel U, Müller Berghaus G, Fuhge P, Eberle R, Heimburger N. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide. Proc Natl Acad Sci USA 1985; 82: 7091-7095
    CrossrefPubMedGoogle Scholar
  • 15 Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch Haehnle B, Draeger B, Naser W, Dessauer A. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coagul Fibrinolysis 1993; 04: 097-102
    CrossrefPubMedGoogle Scholar
  • 16 Dempfle CE, Dollman M, Lill H, Puzzovio D, Dessauer A, Heene DL. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site ‘A’: effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN. Blood Coagul Fibrinolysis 1993; 04: 79-86
    CrossrefPubMedGoogle Scholar
  • 17 Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe ME. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin. Mol Immunol 1983; 20: 1191-1200
    CrossrefPubMedGoogle Scholar
  • 18 Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognizes the NH2-terminal conformation of fragment D. Excerpta medica 1990; 892: 43-48
    PubMedGoogle Scholar
  • 19 Kario K, Matsuo T, Kabayashi H, Matsuo M, Yamamoto K, Sakurai G, Baba M. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay. Thromb Res 1992; 66: 179-189
    CrossrefPubMedGoogle Scholar
  • 20 Kraus M, Aillaud E. Nephelometric determination of plasma D-dimer. Ann Hematol 1994; 68 Suppl 02 A110
    PubMedGoogle Scholar
  • 21 Gogstad GO, Dale S, Brosstad F, Brandsnes O, Holtlund J, Mork E, Gartner E, Borch SM. Assay of D-dimer based on immunofiltration and staining with gold colloids. Clin Chem 1993; 39: 2070-2076
    PubMedGoogle Scholar
  • 22 Gron B, Bennick A, Filion Myklebust C, Matsueda GR, Nieuwenhuizen W, Brosstad F. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen. Thromb Res 1992; 66: 231-238
    CrossrefPubMedGoogle Scholar
  • 23 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 24 Shainoff JR, Dardik BN. Role of fibrinogen in fibrin transport: chromatographic studies. Thromb Res 1980; 17: 491-500
    CrossrefPubMedGoogle Scholar
  • 25 Dardik BN, Shainoff JR. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer. Blood 1985; 65: 680-688
    PubMedGoogle Scholar
  • 26 Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ. et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-778
    CrossrefPubMedGoogle Scholar
  • 27 Dempfle CE, Hafner G, Lestin HG, Tӧpfer G, Adema E, Hubbuch A. Multizentrische Evaluierung von Tina-quant a D-Dimer. J Lab Med 1996; 20: 31-37
    PubMedGoogle Scholar
  • 28 Zamarron C, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator. J Biol Chem 1984; 259: 2080-2083
    PubMedGoogle Scholar
  • 29 Lijnen HR, Van HoefB, de CockF, Collen D. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)-studies with active site mutagenized plasminogen and plasmin resistant t-PA. Thromb Haemost 1990; 64: 61-68
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Wiman B, Ranby M. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 1986; 55: 189-193
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Dempfle CE, Pfitzner SA, Dollman M, Huck K, Stehle G, Heene DL. Comparison of immunological and functional assays for measurement of soluble fibrin. Thromb Haemost 1995; 74: 673-679
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Graeff H, Hafter R, Bachmann L. Subunit and macromolecular structure of circulating fibrin from obstetrics patients with intravascuiar coagulation. Thromb Res 1979; 16: 313-328
    CrossrefPubMedGoogle Scholar
  • 33 Francis CW, Marder BJ, Martin SE. Plasmic degradation of crosslinked fibrin, I. Structural analysis of the particulate clot and indentification of new macromolecular soluble complexes. Blood 1980; 56: 456-464
    PubMedGoogle Scholar
  • 34 Adema E, Gebert U. Pooled patient samples as reference material for D-dimer. Thromb Res 1995; 80: 85-88
    CrossrefPubMedGoogle Scholar
  • 35 Brenner B, Francis CW, Marder VJ. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests. J Lab Clin Med 1989; 113: 682-688
    PubMedGoogle Scholar
  • 36 Gron B, Bennick A, Filion MyklebustC, Brosstad F. Characterization of fibrinogen/fibrin derivatives isolated from normal and fibrinaemic plasma and serum using paramagnetic particles coated with a monoclonal antibody (mAb) to D-dimer. Blood Coagul Fibrinolysis 1993; 04: 447-454
    CrossrefPubMedGoogle Scholar
  • 37 Gron B, Filion MyklebustC, Bennick A, Nieuwenhuizen W, Matsueda GR, Brosstad F. Early cross-linked fibrin in human plasma contains alphapolymers with intact fibrinopeptide A. Blood Coagul Fibrinolysis 1992; 03: 731-736
    CrossrefPubMedGoogle Scholar